Clinical Research Sites
Sell a clinical research site to sponsors, site networks, and investor backed acquirers.
Investigator sites and site networks running sponsored trials.
Clinical research sites and small site networks are pursued by consolidators building therapeutic depth and geographic coverage. Buyers evaluate sponsor relationships, therapeutic focus, enrollment performance, and the strength of the investigator and coordinator team.
A track record of meeting enrollment targets, clean monitoring and audit history, and an engaged patient database are the assets buyers value most. Backlog of awarded studies gives a buyer visibility into revenue after closing.
Preparation includes organizing study contracts and budgets, sponsor and CRO relationships, regulatory binders and audit history, staff credentials and training records, and financials that show study level performance.
Vallexa presents the site confidentially, screens buyers, and manages offers, diligence, and closing coordination.
Marketplace
Current clinical research sites opportunities
Listings are blind by design. Buyers are screened and sign an NDA before identifying details are released.
FAQ
Clinical Research Sites questions owners ask
Do investigators need to stay after closing?
Buyers often want continuity from the principal investigator for a defined period, because sponsors rely on that relationship. Your preferred level of involvement is part of the conversation from the beginning.
Is sponsor information disclosed?
Not in marketing materials. Sponsor and study specifics are shared under NDA once a buyer has demonstrated capacity and relevant experience.
What size sites sell?
Single sites and small networks both transact. Consolidators are often interested in sites that add a therapeutic area or a geography they do not yet cover.
Other industries
Also represented by Vallexa
Find out what your healthcare business is worth
The valuation is free and confidential, and there is no obligation to move forward. If you would rather talk first, call us and speak with an advisor.